Somatuline Autogel 120 mg (Lanreotide (Lanreotide Acetate) SOLUTION (EXTENDED RELEASE)) 120 MG

Somatuline Autogel 120 mg is a subcutaneous solution for extended-release administration. It contains lanreotide acetate, used for managing symptoms related to certain hormonal conditions. This medication is designed for long-term management and is administered via injection.

Strength

120 MG

Pack Size

120MG/SYRINGE

Manufacturer / TM Owner

IPSEN BIOPHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Somatuline Autogel 120 mg is primarily used for the management of symptoms associated with conditions like acromegaly and neuroendocrine tumors. Lanreotide acetate works by regulating hormone levels in the body. It is often prescribed to control symptoms such as excessive growth hormone production or tumor-related hormonal imbalances. Patients may wonder, 'What is Somatuline Autogel used for?' It is typically used to alleviate symptoms and improve quality of life in these conditions.

Side Effects

Common effects of Somatuline Autogel 120 mg may include injection site reactions, gastrointestinal discomfort, and mild headaches. Some users may experience fatigue or dizziness. These effects are generally mild and temporary. However, any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Somatuline Autogel 120 mg should be handled with care to avoid contamination. It is important to follow proper injection techniques and dispose of used syringes safely. Patients with a history of gallbladder disease or diabetes should use this medication under medical supervision. Always store the medication as directed to maintain its efficacy.

Avoid Interactions

Somatuline Autogel 120 mg may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be moderated, as it can exacerbate side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. CYP inhibitors and other drugs that affect liver enzymes may require dose adjustments.

Frequently Asked Questions

Somatuline Autogel 120 mg is used to manage symptoms related to acromegaly and neuroendocrine tumors by regulating hormone levels.

Somatuline Autogel 120 mg is administered via subcutaneous injection, typically every 4 weeks.

Common side effects include injection site reactions, gastrointestinal discomfort, and mild headaches.

Patients should consult their healthcare provider before combining Somatuline Autogel with other medications, especially those metabolized by the liver.

Somatuline Autogel should be stored in a refrigerator between 2°C and 8°C, protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.